List view / Grid view

Dr Aaron Haubner (Senior Manager of North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies)

 

article

Automated red blood cell exchange: bridging treatment gaps in sickle cell disease care

5 June 2025 | By ,

Despite the promise of gene therapies, automated red blood cell exchange (aRBCX) remains an underutilised therapy in the management of sickle cell disease (SCD). In this article, Dr Aaron Haubner and Carly Newton of Terumo Blood and Cell Technologies, highlight the urgent need for partnerships and equitable access to this…